AFTX-201 is designed using Affinia's proprietary capsid engineered for efficient cardiac transduction at doses that are 5-10-fold lower than doses of gene therapies using conventional capsids WALTHAM, ...

AFTX-201 uses a proprietary capsid to deliver a human BAG3 transgene, aiming to restore cardiac function with lower doses than conventional gene therapies.

Please provide your email address to receive an email when new articles are posted on . Genetic risk for dilated cardiomyopathy was tied to elevated risk for secondary cardiomyopathies related to ...

Please provide your email address to receive an email when new articles are posted on . Among patients with dilated cardiomyopathy on implantable cardioverter defibrillator or cardiac ...

New gene editing techniques, like adenine base editing and prime editing, are creating new possibilities for treating dilated cardiomyopathy, a heart condition affecting about 1 in 250 people ...

More than a quarter of adults receiving specialized care for idiopathic dilated cardiomyopathy (DCM) had parents, siblings, or children with the disorder, particularly among those who were Black, in ...

Women with dilated cardiomyopathy (DCM) have an increased burden of maternal morbidity and mortality during and after pregnancy.

Cardiomyopathy can be a diverse diagnosis. There are many different types -- some inherited, others due to injury to the heart, treatment side effects, pregnancy, and a range of other causes. The ...